Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)

NCT05526144 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT05526144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05526144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Recruiting
Start date
April 1, 2023
Completion date
December 31, 2029
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver fibrosis, nonalcoholic steatohepatitis